§ Mr. BurstowTo ask the Secretary of State for Health what assessment he has made of the availability of the anti-dementia drug Ebixa. [140111]
§ Dr. LadymanThe National Institute for Clinical Excellence (NICE) will appraise Memantine (Ebixa), for the treatment of moderate to severe dementia, as part of the eighth wave of its work programme. The anticipated publication date of its recommendations is May 2005.
Until NICE has made its recommendations it is for local areas to make decisions about availability on the national health service having taken account of published evidence.